Payment partnership with Klarna
19/06/2023 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230619:nRSS0551Da&default-theme=true
RNS Number : 0551D Cellular Goods PLC 19 June 2023
Press release
19 June 2023
Cellular Goods PLC
("Cellular Goods" or "the Company")
Payment partnership with Klarna
Cellular Goods (LSE: CBX) a UK-based skincare and wellness company providing
premium consumer products formulated with lab-produced cannabinoids, is
pleased to announce that it has signed an agreement with Klarna Bank AB
("Klarna"), a Swedish provider of online financial services, to bring Klarna's
buy now, pay later (BNPL) services to Cellular Goods' ecommerce website.
Through the partnership consumers buying products on www.cellular-goods.com
(http://www.cellular-goods.com) can choose to split payment across three equal
instalments or can choose to defer payment for up to 30 days with zero
interest and no additional fees. The new payment options will be available to
all customers in the United Kingdom.
Cellular Goods believes that offering flexible purchase options will support
increased sales and open the Company's products up to new audiences.
Demand for buy now, pay later payment services has surged among all age groups
in the UK and is popular with shoppers across Cellular Goods' target
demographics. While the age group using BNPL services most frequently is
25-34-year-olds, the fastest-growing group of BNPL users in the UK is now
comprised of older and more affluent customers in the 45 and above age cohort
(Source: Experian, 2023).
Darcy Taylor, chairman and interim CEO, commented: "The partnership with
Klarna is an important improvement to our ecommerce offering and responds to a
growing consumer trend. Providing our customers with a range of flexible
payment methods enhances their shopping experience and expands our reach to
new audiences."
For further information please contact:
Cellular Goods
Darcy Taylor via Tancredi +44 207 887 7633
Chairman and interim CEO
Neil Thapar +44 787 645 5323
Investor Relations
First Sentinel Corporate Finance
Corporate Broker & Advisor
Brian Stockbridge +44 7876 888 011
Novum Securities
Corporate Broker
Colin Rowbury
Jon Belliss +44 207 399 9427
Tancredi Intelligent Communication
Media Relations
Helen Humphrey +44 744 922 6720
Charlie Hobbs +44 789 755 7112
cellulargoods@tancredigroup.com (mailto:cellulargoods@tancredigroup.com)
About Cellular Goods PLC:
Cellular Goods develops and markets premium quality skincare and wellness
products based on proprietary formulations incorporating biosynthetic lab-made
cannabinoids. Our branded products are efficacy-led and research-backed and
available online in the UK and US. The Company is incorporated in the UK and
listed on the Main Market of the London Stock Exchange. For more information,
visit www.cellular-goods.com (http://www.cellular-goods.com) .
About Klarna:
Since 2005 Klarna has been on a mission to revolutionize the retail banking
industry. With over 150 million global active users and 2 million transactions
per day, Klarna is meeting the changing demands of consumers by saving them
time and money while helping them be informed and in control. Over 500,000
global retail partners, including H&M, Saks, Sephora, Macys, IKEA, Expedia
Group, and Nike have integrated Klarna's innovative technology to deliver a
seamless shopping experience online and in-store. Klarna has over 5,000
employees and is active in 45 markets. For more information, visit Klarna.com.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAEASKKFDXDEFA